If you or someone you love uses high-potency cannabis products regularly, this research suggests the mental health risks are real—especially for younger users whose brains are still developing. A study published in the Journal of Ethnopharmacology found that 10 non-psychotropic phytocannabinoids—particularly CBDV and CBG—demonstrated meaningful anti-inflammatory effects. Researchers from the University of Chemistry and Technology and the Czech Academy of Sciences found that CBDV significantly reduced IL-6 and TNF-α production and inhibited NF-κB activation.